Top

Published in:

Open Access 06-10-2022 | Breast Cancer | Surgical Techniques and Innovations

Radiofrequency Identification—RFID using LOCalizer-Tag in Non-palpable Breast Lump

Authors: Simona Parisi, Claudio Gambardella, Roberto Ruggiero, Salvatore Tolone, Francesco Saverio Lucido, Ludovico Docimo

Published in: Indian Journal of Surgery | Issue 4/2023

Abstract

For many years, wire-guided localization represented the gold standard method for the detection of non-palpable breast lesions, despite the acknowledged limitations. LOCalizer™ is the most recent and promising radiofrequency identification system, characterized by the capability of measuring the distance from the tagged lesion in millimeters and the association of each marker with a unique code. A 45-year-old woman with two lesions suspected of cancer in the same breast was referred to our department. She underwent double localization with LOCalizer™ (Hologic, Santa Carla, CA, USA) of the lumps into opposite quadrants. We performed a mini-invasive and oncologically safe surgical excision through a tunneling approach after a peri-areolar incision. The surgical technique realized with Localizer™ could be an effective method for locating multiple non-palpable breast lesions and is able to offer excellent oncological and cosmetic results, as also confirmed by several reports in the literature.

Chan BK, Wiseberg-Firtell JA, Jois RH, Jensen K, Audisio RA (2015) Localization techniques for guided surgical excision of non-palpable breast lesions. Cochrane Database Syst Rev 31(12):CD009206. https://doi.org/10.1002/14651858.CD009206.pub2CrossRef

Tardioli S, Ballesio L, Gigli S, DI Pastena F, D’Orazi V, Giraldi G et al (2016) Wire-guided localization in non-palpable breast cancer: results from monocentric experience. Anticancer Res 36(5):2423–2427PubMed

Hayes MK (2017) Update on preoperative breast localization. Radiol Clin North Am 55(3):591–603. https://doi.org/10.1016/j.rcl.2016.12.012CrossRefPubMed

Cullinane CM, Byrne J, Akmenkalne L, O’ Leary DP, Connors AM, Corrigan MA et al (2021) The LOCalizer radiofrequency identification system: an effective new technology for localizing non-palpable breast lesions for surgery. Surg Innov 28(4):473–478. https://doi.org/10.1177/1553350620967853CrossRefPubMed

Nuclear Regulatory Commission. Iodine-125 and Palladium-103 low dose rate brachytherapy seeds used for localization of non-palpable lesions n.d. https://www.nrc.gov/materials/miau/med-use-toolkit/seed-localization.html (Accessed 7 Aug 2018)

DiNome ML, Kusske AM, Attai DJ, Fischer CP, Hoyt AC (2019) Microchipping the breast: an effective new technology for localizing non-palpable breast lesions for surgery. Breast Cancer Res Treat 1:165–170. https://doi.org/10.1007/s10549-019-05143-wCrossRef

Parisi S, Ruggiero R, Gualtieri G, Volpe ML, Rinaldi S, Nesta G et al (2021) Combined LOCalizerTM and intraoperative ultrasound localization: first experience in localization of non-palpable breast cancer. In Vivo 35:1669–76. https://doi.org/10.21873/invivo.12426CrossRefPubMedPubMedCentral

Lowes S, Bell A, Milligan R, Amonkar S, Leaver A (2020) Use of hologic LOCalizer radiofrequency identification (RFID) tags to localise impalpable breast lesions and axillary nodes: experience of the first 150 cases in a UK breast unit. Clin Radiol 12:942–949. https://doi.org/10.1016/j.crad.2020.08.014CrossRef

Brown CL, McEvoy MP, Smith BL, Lanahan CR, Kelly BN, Coopey SB et al (2020) Long- term outcomes of multiple-wire localizations for more extensive breast cancer: multiple-wire excision does not increase recurrence, unplanned imaging, or biopsies. Clin Breast Cancer 20(3):215–219. https://doi.org/10.1016/j.clbc.2019.11.006CrossRefPubMed

10.

Kirstein LJ, Rafferty E, Specht MC, Moore RH, Taghian AG, Hughes KS et al (2008) Outcomes of multiple wire localization for larger breast cancers: when can mastectomy be avoided? J Am Coll Surg 207(3):342–346. https://doi.org/10.1016/j.jamcollsurg.2008.04.019CrossRefPubMed

11.

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339:b2700CrossRefPubMedPubMedCentral

12.

Tayeh S, Gera R, Perry N, Michell M, Malhotra A, Mokbel K (2020) The use of magnetic seeds and radiofrequency identifier tags in breast surgery for non-palpable lesions. Anticancer Res 1:315–21. https://doi.org/10.21873/anticanres.13955CrossRef

13.

Malter W, Holtschmidt J, Thangarajah F, Mallmann P, Krug B, Warm M et al (2019) First reported use of the Faxitron LOCalizerTM Radiofrequency Identification (RFID) system in Europe - a feasibility trial, surgical guide and review for non-palpable breast lesions. In Vivo 5:1559–64. https://doi.org/10.21873/invivo.11637CrossRef

14.

Lamb LR, Gilman L, Specht M, D’Alessandro HA, Miles RC, Lehman CD (2020) Retrospective review of preoperative radiofrequency tag localization of breast lesions in 848 patients. AJR Am J Roentgenol 217:605–612. https://doi.org/10.2214/AJR.20.24374CrossRefPubMed

15.

McGugin C, Spivey T, Coopey S, Smith B, Kelly B, Gadd M et al (2019) Radiofrequency identification tag localization is comparable to wire localization for non-palpable breast lesions. Breast Cancer Res Treat 3:735–739. https://doi.org/10.1007/s10549-019-05355-0CrossRef

16.

Dauphine C, Reicher JJ, Reicher MA, Gondusky C, Khalkhali I, Kim M (2015) A prospective clinical study to evaluate the safety and performance of wireless localization of nonpalpable breast lesions using radiofrequency identification technology. AJR Am J Roentgenol 6:W720–W723. https://doi.org/10.2214/AJR.14.13201CrossRef

17.

Tayeh S, Wazir U, Mokbel K (2021) The evolving role of radiofrequency guided localisation in breast surgery: a systematic review. Cancers (Basel) 13:4996. https://doi.org/10.3390/cancers13194996CrossRefPubMed

18.

Wazir U, Tayeh S, Perry N, Michell M, Malhotra A, Mokbel K (2020) Wireless breast localization using radio-frequency identification tags: the first reported European experience in breast cancer. In Vivo 1:233. https://doi.org/10.21873/invivo.11765CrossRef

19.

Lee MK, Sanaiha Y, Kusske AM, Thompson CK, Attai DJ, Baker JL, et al (2020) A comparison of two non-radioactive alternatives to wire for the localization of non- palpable breast cancers. Breast Cancer Res Treat 182299–303. https://doi.org/10.1007/s10549-020-05707-1

20.

Goudreau SH (2021) Editorial comment: preoperative radiofrequency tag localization of breast lesions is a safe and reliable localization alternative. AJR Am J Roentgenol 217(3):612. https://doi.org/10.2214/AJR.20.25007CrossRefPubMed

Title: Radiofrequency Identification—RFID using LOCalizer-Tag in Non-palpable Breast Lump
Authors: Simona Parisi
Claudio Gambardella
Roberto Ruggiero
Salvatore Tolone
Francesco Saverio Lucido
Ludovico Docimo
Publication date: 06-10-2022
Publisher: Springer India
Keywords: Breast Cancer
Breast Cancer
Published in: Indian Journal of Surgery / Issue 4/2023
Print ISSN: 0972-2068
Electronic ISSN: 0973-9793
DOI: https://doi.org/10.1007/s12262-022-03575-1

At a glance: The STEP trials

Springer Medicine

Radiofrequency Identification—RFID using LOCalizer-Tag in Non-palpable Breast Lump

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2023

Supporting Struggling Trainees with Performance Issues: Lessons from a UK Model

Esophageal Candidiasis

Reducing Surgical Site Infection in Colorectal Surgery Using Mechanical Bowel Preparation and Oral Antibiotics: a Comparative Study in the Era of Enhanced Recovery After Surgery (ERAS) Protocol

Black Esophagus: Acute Esophageal Necrosis

Comparison of Bismuth IIIa and IIIb Types of Hilar Cholangiocarcinoma: a Multi-center Case Series Analysis of China

Predictors of Successful Management of Renal Calculus Disease in Horseshoe Kidney